8-K
false000104950200010495022022-11-022022-11-02

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 02, 2022

 

 

MKS INSTRUMENTS, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Massachusetts

000-23621

04-2277512

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

2 Tech Drive

Suite 201

 

Andover, Massachusetts

 

01810

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 978 645-5500

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, no par value

 

MKSI

 

NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


Item 2.02 Results of Operations and Financial Condition.

On November 2, 2022, MKS Instruments, Inc. announced its financial results for the quarter ended September 30, 2022. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

99.1 Press Release dated November 2, 2022

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MKS Instruments, Inc.

 

 

 

 

Date:

November 2, 2022

By:

/s/ Seth H. Bagshaw

 

 

 

Name: Seth H. Bagshaw
Title: Senior Vice President, Chief Financial Officer and Treasurer

 


EX-99.1

https://cdn.kscope.io/b4d70eeabd41fb6eec644ac3cd367653-img23390321_0.jpg 

EXHIBIT 99.1

 

MKS Instruments Reports Third Quarter 2022 Financial Results

 

Record quarterly revenue of $954 million
Non-GAAP net earnings per diluted share of $2.74 and GAAP net income per diluted share of $0.09
Successfully completed acquisition of Atotech Limited, adding critical chemistry solutions for advanced electronics and specialty industrial markets to MKS' portfolio

Andover, MA, November 2, 2022 -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today reported third quarter 2022 financial results.

"We delivered a strong third quarter driven by robust demand for our vacuum and photonics solutions," said John T.C. Lee, President and Chief Executive Officer. "While end market demand in our Semiconductor and Advanced Electronics markets is expected to soften in the fourth quarter and into 2023, we believe our market leadership in critical technologies for advanced device manufacturing, our operational track record, and our significant base of consumables and services revenue position MKS to emerge from this changing market landscape even stronger than when we entered into it."

Mr. Lee added, "The third quarter also marked a major advancement in MKS' long-term strategy, as we completed the acquisition of Atotech Limited. Atotech broadens MKS' capabilities by adding leadership in critical chemistry solutions for advanced electronics and specialty industrial applications. We are thrilled to welcome the talented global team of over 4,000 new employees to the MKS family."

"We delivered revenues above the midpoint of our guidance range, and are especially pleased with the 100 basis point sequential improvement in Non-GAAP operating margin," said Seth H. Bagshaw, Senior Vice President and Chief Financial Officer. "This performance is a testament to our track record of prudent cost management."

Mr. Bagshaw added, "We exited the third quarter with a net leverage ratio of 3.3. We have a well-established history of rapidly paying down debt following each major acquisition, and will be focused on doing so again in the coming quarters."

Fourth Quarter 2022 Outlook

Based on current business levels, regulatory environment, and certain supply chain constraints, the Company expects revenue in the fourth quarter of 2022 of $1.00 billion, plus or minus $50 million. At these volumes, the Company expects Non-GAAP net earnings per diluted share of $1.34, plus or minus $0.27.


Conference Call Details

A conference call with management will be held on Thursday, November 3, 2022 at 8:30 a.m. (Eastern Time). To participate in the call by phone, participants should visit the Investor Relations section of MKS' website at www.mks.com and click on Calendar of Events, where you will be able to register online and receive dial-in details. We encourage participants to register and dial in to the conference call at least 15 minutes before the start of the call to ensure a timely connection. A live and archived webcast and related presentation materials will be available on MKS' website.

About MKS Instruments

MKS Instruments, Inc. enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, advanced electronics and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world's leading technology and industrial companies. Our solutions are critical to addressing the challenges of miniaturization and complexity in advanced device manufacturing by enabling increased power, speed and feature enhancement for optimized connectivity. Our solutions are also critical to addressing ever-increasing performance requirements across a wide array of specialty industrial applications. Additional information can be found at www.mks.com.


Use of Non-GAAP Financial Results

This press release includes financial measures that are not in accordance with U.S. generally accepted accounting principles ("Non-GAAP financial measures"). These Non-GAAP financial measures should be viewed in addition to, and not as a substitute for, MKS' reported results under U.S. generally accepted accounting principles ("GAAP"), and may be different from Non-GAAP financial measures used by other companies. In addition, these Non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. MKS management believes the presentation of these Non-GAAP financial measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results.

MKS is not providing a quantitative reconciliation of forward-looking Non-GAAP gross margin, operating expenses, interest expense, net, income tax rate, net earnings, net earnings per diluted share and adjusted EBITDA to the most directly comparable GAAP financial measures because it is unable to estimate with reasonable certainty the ultimate timing or amount of certain significant items without unreasonable efforts. These items include, but are not limited to, acquisition and integration costs, acquisition inventory step-up, amortization of intangible assets, restructuring and other expense, asset impairment, and the income tax effect of these items. These items are uncertain, depend on various factors, including, but not limited to, our recent acquisition of Atotech and could have a material impact on GAAP reported results for the relevant period.

For further information regarding these Non-GAAP financial measures, please refer to the tables presenting reconciliations of our Non-GAAP results to our GAAP results and the "Notes on Our Non-GAAP Financial Information" at the end of this press release.

 

 


Selected GAAP and Non-GAAP Financial Measures

(In millions, except per share data)

 

 

 

 

 

 

 

 

 

 

 

Year to Date

 

 

Q3 2022

 

 

Q2 2022

 

 

Q3 2021

 

 

Q3 2022

 

 

Q3 2021

 

Net Revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Semiconductor

$

541

 

 

$

515

 

 

$

488

 

 

$

1,545

 

 

$

1,331

 

Advanced Electronics

 

185

 

 

 

77

 

 

 

90

 

 

 

344

 

 

 

342

 

Specialty Industrial

 

228

 

 

 

173

 

 

 

164

 

 

 

572

 

 

 

513

 

Total net revenues

$

954

 

 

$

765

 

 

$

742

 

 

$

2,461

 

 

$

2,186

 

GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

40.8

%

 

 

44.2

%

 

 

47.0

%

 

 

43.1

%

 

 

46.9

%

Operating margin

 

12.4

%

 

 

21.5

%

 

 

23.6

%

 

 

18.4

%

 

 

23.7

%

Net income

$

6

 

 

$

130

 

 

$

132

 

 

$

279

 

 

$

401

 

Diluted EPS

$

0.09

 

 

$

2.32

 

 

$

2.38

 

 

$

4.84

 

 

$

7.21

 

Non-GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin

 

44.9

%

 

 

44.2

%

 

 

47.0

%

 

 

44.7

%

 

 

46.9

%

Operating margin

 

25.1

%

 

 

24.1

%

 

 

27.1

%

 

 

24.9

%

 

 

26.9

%

Net earnings

$

167

 

 

$

145

 

 

$

155

 

 

$

464

 

 

$

466

 

Diluted EPS

$

2.74

 

 

$

2.59

 

 

$

2.79

 

 

$

8.05

 

 

$

8.36

 

 

Additional Financial Information

At September 30, 2022, the Company had $885 million in cash and short-term investments, $5.2 billion of secured term loan principal outstanding, and up to $500 million of additional borrowing capacity under a revolving credit facility, subject to certain leverage ratio requirements. During the third quarter of 2022, the Company paid a cash dividend of $12 million or $0.22 per diluted share.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding the future financial performance, business prospects and growth of MKS Instruments, Inc. ("MKS" or the "Company"). These statements are only predictions based on current assumptions and expectations. Any statements that are not statements of historical fact (including statements containing the words "will," "projects," "intends," "believes," "plans," "anticipates," "expects," "estimates," "forecasts," "continues" and similar expressions) should be considered to be forward-looking statements. Actual events or results may differ materially from those in the forward-looking statements set forth herein. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements are the need to generate sufficient cash flows to service and repay the substantial indebtedness MKS has incurred in connection with the acquisition of Atotech, the terms of the existing term loans under which MKS incurred such debt, MKS' entry into the chemicals technology business through its acquisition of Atotech, in which MKS does not have experience and which may expose MKS to significant additional liabilities, the risk of litigation relating to the Atotech acquisition, the risk that disruption from the Atotech acquisition


materially and adversely affects MKS' businesses and operations, MKS' ability to realize the anticipated synergies, cost savings and other benefits of the Atotech acquisition, competition from larger, more advanced or more established companies in MKS' markets, MKS' ability to successfully grow its business and the businesses of Atotech, which MKS acquired in August 2022, and Electro Scientific Industries, Inc., which MKS acquired in February 2019, and financial risks associated with those and potential future acquisitions, including goodwill and intangible asset impairments, potential adverse reactions or changes to business relationships resulting from the completion of the Atotech acquisition, manufacturing and sourcing risks, including those associated with limited and sole source suppliers and the impact and duration of supply chain disruptions and component shortages, and changes in global demand and the impact of COVID-19 or any other pandemic with respect to such disruptions, shortages and increases, risks associated with doing business internationally, including trade compliance, regulatory restrictions on MKS' products or components and unfavorable currency exchange and tax rate fluctuations, which risks become more significant as MKS grows its business internationally and in China specifically, conditions affecting the markets in which MKS operates, including fluctuations in capital spending in the semiconductor industry and other advanced manufacturing markets, and fluctuations in sales to MKS' major customers or disruptions or delays from third-party service providers upon which our operations may rely, the ability to anticipate and meet customer demand, the challenges, risks and costs involved with integrating or transitioning local and international operations of the companies MKS has acquired, risks associated with the attraction and retention of key personnel, potential fluctuations in quarterly results, dependence on new product development, rapid technological and market change, acquisition strategy, volatility of stock price, risks associated with chemical manufacturing and environmental regulation compliance, risks related to MKS' products resulting from defects, which would increase MKS' costs and seriously harm the business, financial condition, operating results and customer relationships, financial and legal risk management, risks related to cybersecurity and data privacy threats and the challenges associated with intellectual property protection, and the other factors described in Exhibit 99.1 to MKS' Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on August 17, 2022, and any subsequent Quarterly Reports on Form 10-Q. MKS is under no obligation to, and expressly disclaim any obligation to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise after the date of this press release.

###

Company Contact:

David Ryzhik

Vice President, Investor Relations

Telephone: (978) 557-5180

Email: david.ryzhik@mksinst.com

 

 

 


MKS Instruments, Inc.

Unaudited Consolidated Statements of Operations

(In millions, except per share data)

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

June 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

2022

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Net revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

$

841

 

 

$

664

 

 

$

649

 

 

$

2,153

 

 

$

1,911

 

Services

 

113

 

 

 

101

 

 

 

93

 

 

 

308

 

 

 

275

 

Total net revenues

 

954

 

 

 

765

 

 

 

742

 

 

 

2,461

 

 

 

2,186

 

Cost of revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

506

 

 

 

377

 

 

 

345

 

 

 

1,243

 

 

 

1,012

 

Services

 

58

 

 

 

50

 

 

 

49

 

 

 

156

 

 

 

148

 

Total cost of revenues

 

564

 

 

 

427

 

 

 

394

 

 

 

1,399

 

 

 

1,160

 

Gross profit

 

390

 

 

 

338

 

 

 

348

 

 

 

1,062

 

 

 

1,026

 

Research and development

 

63

 

 

 

53

 

 

 

52

 

 

 

168

 

 

 

149

 

Selling, general and administrative

 

126

 

 

 

101

 

 

 

95

 

 

 

319

 

 

 

289

 

Acquisition and integration costs

 

31

 

 

 

2

 

 

 

9

 

 

 

41

 

 

 

21

 

Restructuring and other

 

5

 

 

 

3

 

 

 

2

 

 

 

10

 

 

 

10

 

Amortization of intangible assets

 

47

 

 

 

15

 

 

 

15

 

 

 

77

 

 

 

40

 

Gain on sale of long-lived assets

 

 

 

 

 

 

 

 

 

 

(7

)

 

 

 

Income from operations

 

118

 

 

 

164

 

 

 

175

 

 

 

454

 

 

 

517

 

Interest income

 

1

 

 

 

1

 

 

 

 

 

 

2

 

 

 

1

 

Interest expense

 

80

 

 

 

7

 

 

 

6

 

 

 

93

 

 

 

19

 

Other (income) expense, net

 

(1

)

 

 

2

 

 

 

3

 

 

 

(4

)

 

 

12

 

Income before income taxes

 

40

 

 

 

156

 

 

 

166

 

 

 

367

 

 

 

487

 

Provision for income taxes

 

34

 

 

 

26

 

 

 

34

 

 

 

88

 

 

 

86

 

Net income

$

6

 

 

$

130

 

 

$

132

 

 

$

279

 

 

$

401

 

Net income per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.09

 

 

$

2.33

 

 

$

2.39

 

 

$

4.85

 

 

$

7.24

 

Diluted

$

0.09

 

 

$

2.32

 

 

$

2.38

 

 

$

4.84

 

 

$

7.21

 

Cash dividend per common share

$

0.22

 

 

$

0.22

 

 

$

0.22

 

 

$

0.66

 

 

$

0.64

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

61.0

 

 

 

55.7

 

 

 

55.5

 

 

 

57.4

 

 

 

55.4

 

Diluted

 

61.1

 

 

 

55.8

 

 

 

55.7

 

 

 

57.6

 

 

 

55.7

 

 


MKS Instruments, Inc.

Unaudited Consolidated Balance Sheet

(In millions)

 

 

 

 

September 30,

 

 

December 31,

 

 

 

2022

 

 

2021

 

ASSETS

 

 

 

 

 

 

Cash and cash equivalents

 

$

884

 

 

$

966

 

Short-term investments

 

 

1

 

 

 

76

 

Trade accounts receivable, net

 

 

730

 

 

 

443

 

Inventories

 

 

961

 

 

 

577

 

Other current assets

 

 

215

 

 

 

85

 

Total current assets

 

 

2,791

 

 

 

2,147

 

Property, plant and equipment, net

 

 

655

 

 

 

326

 

Right-of-use assets

 

 

235

 

 

 

184

 

Goodwill

 

 

3,851

 

 

 

1,228

 

Intangible assets, net

 

 

3,653

 

 

 

576

 

Other assets

 

 

187

 

 

 

79

 

Total assets

 

$

11,372

 

 

$

4,540

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

Short-term debt

 

$

95

 

 

$

9

 

Accounts payable

 

 

410

 

 

 

168

 

Accrued compensation

 

 

92

 

 

 

132

 

Income taxes payable

 

 

92

 

 

 

25

 

Lease liabilities

 

 

27

 

 

 

18

 

Deferred revenue and customer advances

 

 

103

 

 

 

37

 

Other current liabilities

 

 

192

 

 

 

71

 

Total current liabilities

 

 

1,011

 

 

 

460

 

Long-term debt, net

 

 

4,893

 

 

 

808

 

Non-current deferred taxes

 

 

893

 

 

 

99

 

Non-current accrued compensation

 

 

131

 

 

 

49

 

Non-current lease liabilities

 

 

220

 

 

 

193

 

Other liabilities

 

 

75

 

 

 

44

 

Total liabilities

 

 

7,223

 

 

 

1,653

 

Stockholders' equity

 

 

 

 

 

 

Common stock

 

 

 

 

 

 

Additional paid-in capital

 

 

2,124

 

 

 

907

 

Retained earnings

 

 

2,233

 

 

 

1,991

 

Accumulated other comprehensive loss

 

 

(208

)

 

 

(11

)

Total stockholders' equity

 

 

4,149

 

 

 

2,887

 

Total liabilities and stockholders' equity

 

$

11,372

 

 

$

4,540

 

 


MKS Instruments, Inc.

Unaudited Consolidated Statements of Cash Flows

(In millions)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

June 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

2022

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

$

6

 

 

$

130

 

 

$

132

 

 

$

279

 

 

$

401

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

64

 

 

 

28

 

 

 

27

 

 

 

120

 

 

 

76

 

Amortization of inventory step-up adjustment to fair value

 

39

 

 

 

 

 

 

 

 

 

39

 

 

 

 

Unrealized (gain) loss on derivatives not designated as hedging instruments

 

(1

)

 

 

4

 

 

 

(8

)

 

 

6

 

 

 

(1

)

Amortization of debt issuance costs and original issue discounts

 

46

 

 

 

 

 

 

1

 

 

 

46

 

 

 

2

 

Gain on sale of long-lived assets

 

 

 

 

 

 

 

 

 

 

(7

)

 

 

 

Stock-based compensation

 

10

 

 

 

13

 

 

 

9

 

 

 

31

 

 

 

28

 

Provision for excess and obsolete inventory

 

3

 

 

 

3

 

 

 

5

 

 

 

10

 

 

 

14

 

Deferred income taxes

 

6

 

 

 

 

 

 

(2

)

 

 

4

 

 

 

7

 

Other

 

1

 

 

 

2

 

 

 

1

 

 

 

3

 

 

 

1

 

Changes in operating assets and liabilities, net of acquired assets and liabilities

 

25

 

 

 

(75

)

 

 

(12

)

 

 

(186

)

 

 

(83

)

Net cash provided by operating activities

 

199

 

 

 

105

 

 

 

153

 

 

 

345

 

 

 

445

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition of business, net of cash acquired

 

(4,473

)

 

 

 

 

 

(268

)

 

 

(4,473

)

 

 

(268

)

Purchases of investments

 

 

 

 

(1

)

 

 

(100

)

 

 

(1

)

 

 

(497

)

Maturities of investments

 

 

 

 

41

 

 

 

138

 

 

 

76

 

 

 

342

 

Sales of investments

 

 

 

 

 

 

 

 

 

 

 

 

 

135

 

Proceeds from sale of long-lived assets

 

 

 

 

 

 

 

 

 

 

7

 

 

 

 

Purchases of property, plant and equipment

 

(26

)

 

 

(64

)

 

 

(21

)

 

 

(109

)

 

 

(63

)

Net cash used in investing activities

 

(4,499

)

 

 

(24

)

 

 

(251

)

 

 

(4,500

)

 

 

(351

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net proceeds from borrowings

 

4,979

 

 

 

3

 

 

 

 

 

 

4,985

 

 

 

1

 

Payments of borrowings

 

(826

)

 

 

(6

)

 

 

(2

)

 

 

(835

)

 

 

(13

)

Dividend payments

 

(13

)

 

 

(12

)

 

 

(12

)

 

 

(37

)

 

 

(36

)

Net proceeds (payments) related to employee stock awards

 

 

 

 

1

 

 

 

(7

)

 

 

(5

)

 

 

(14

)

Net cash provided by (used) in financing activities

 

4,140

 

 

 

(14

)

 

 

(21

)

 

 

4,108

 

 

 

(62

)

Effect of exchange rate changes on cash and cash equivalents

 

(21

)

 

 

(13

)

 

 

(3

)

 

 

(35

)

 

 

(7

)

(Decrease) increase in cash and cash equivalents

 

(181

)

 

 

54

 

 

 

(122

)

 

 

(82

)

 

 

25

 

Cash and cash equivalents at beginning of period

 

1,065

 

 

 

1,011

 

 

 

755

 

 

 

966

 

 

 

608

 

Cash and cash equivalents at end of period

$

884

 

 

$

1,065

 

 

$

633

 

 

$

884

 

 

$

633

 

 

 


The following supplemental Non-GAAP earnings information is presented to aid in understanding MKS' operating results:

 

 

MKS Instruments, Inc.

Schedule Reconciling Selected Non-GAAP Financial Measures

(In millions, except per share data)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

June 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

2022

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Net income

$

6

 

 

$

130

 

 

$

132

 

 

$

279

 

 

$

401

 

Acquisition and integration costs (Note 1)

 

31

 

 

 

2

 

 

 

9

 

 

 

41

 

 

 

21

 

Acquisition inventory step-up (Note 2)

 

39

 

 

 

 

 

 

 

 

 

39

 

 

 

 

Restructuring and other (Note 3)

 

5

 

 

 

3

 

 

 

2

 

 

 

10

 

 

 

10

 

Amortization of intangible assets

 

47

 

 

 

15

 

 

 

15

 

 

 

77

 

 

 

40

 

Amortization of debt issuance costs (Note 4)

 

43

 

 

 

 

 

 

 

 

 

43

 

 

 

1

 

Gain on sale of long-lived assets (Note 5)

 

 

 

 

 

 

 

 

 

 

(7

)

 

 

 

Currency hedge loss (gain) (Note 6)

 

 

 

 

 

 

 

3

 

 

 

(5

)

 

 

10

 

Reversal of indefinite reinvestment assertion (Note 7)

 

30

 

 

 

 

 

 

 

 

 

30

 

 

 

 

Windfall tax benefit on stock-based compensation (Note 8)

 

 

 

 

 

 

 

 

 

 

(1

)

 

 

(4

)

Withholding tax related to Brexit (Note 9)

 

 

 

 

 

 

 

 

 

 

 

 

 

3

 

Tax effect of Non-GAAP adjustments (Note 10)

 

(34

)

 

 

(5

)

 

 

(6

)

 

 

(42

)

 

 

(16

)

Non-GAAP net earnings

$

167

 

 

$

145

 

 

$

155

 

 

$

464

 

 

$

466

 

Non-GAAP net earnings per diluted share

$

2.74

 

 

$

2.59

 

 

$

2.79

 

 

$

8.05

 

 

$

8.36

 

Weighted average diluted shares outstanding

 

61.1

 

 

 

55.8

 

 

 

55.7

 

 

 

57.6

 

 

 

55.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

$

199

 

 

$

105

 

 

$

153

 

 

$

345

 

 

$

445

 

Purchases of property, plant and equipment

 

(26

)

 

 

(64

)

 

 

(21

)

 

 

(109

)

 

 

(63

)

Free cash flow

$

173

 

 

$

41

 

 

$

132

 

 

$

236

 

 

$

382

 

 

 


MKS Instruments, Inc.

Schedule Reconciling Selected Non-GAAP Financial Measures

(In millions)

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

June 30,

 

 

September 30,

 

 

September 30,

 

 

September 30,

 

 

2022

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Gross profit

$

390

 

 

$

338

 

 

$

348

 

 

$

1,062

 

 

$

1,026

 

Acquisition inventory step-up (Note 2)

 

39

 

 

 

 

 

 

 

 

 

39

 

 

 

 

Non-GAAP gross profit

 

429

 

 

 

338

 

 

 

348

 

 

 

1,101

 

 

 

1,026

 

Non-GAAP gross margin

 

44.9

%

 

 

44.2

%

 

 

47.0

%

 

 

44.7

%

 

 

46.9

%

Operating expenses

$

272

 

 

$

174

 

 

$

173

 

 

$

608

 

 

$

509

 

Acquisition and integration costs (Note 1)

 

31

 

 

 

2

 

 

 

9

 

 

 

41

 

 

 

21

 

Restructuring and other (Note 3)

 

5

 

 

 

3

 

 

 

2

 

 

 

10

 

 

 

10

 

Gain on sale of long-lived assets (Note 5)

 

 

 

 

 

 

 

 

 

 

(7

)

 

 

 

Amortization of intangible assets

 

47

 

 

 

15

 

 

 

15

 

 

 

77

 

 

 

40

 

Non-GAAP operating expenses

$

189

 

 

$

154

 

 

$

147

 

 

$

487

 

 

$

438

 

Income from operations

$

118

 

 

$

164

 

 

$

175

 

 

$

454

 

 

$

517

 

Acquisition and integration costs (Note 1)

 

31

 

 

 

2

 

 

 

9

 

 

 

41

 

 

 

21

 

Acquisition inventory step-up (Note 2)

 

39

 

 

 

 

 

 

 

 

 

39

 

 

 

 

Restructuring and other (Note 3)

 

5

 

 

 

3

 

 

 

2

 

 

 

10

 

 

 

10

 

Gain on sale of long-lived assets (Note 5)

 

 

 

 

 

 

 

 

 

 

(7

)

 

 

 

Amortization of intangible assets

 

47

 

 

 

15

 

 

 

15

 

 

 

77

 

 

 

40

 

Non-GAAP income from operations

$

240

 

 

$

184

 

 

$

201

 

 

$

614

 

 

$

588

 

Non-GAAP operating margin

 

25.1

%

 

 

24.1

%

 

 

27.1

%

 

 

24.9

%

 

 

26.9

%

Interest expense, net

 

79

 

 

 

6

 

 

 

6

 

 

 

91

 

 

 

18

 

Amortization of debt issuance costs (Note 4)

 

43

 

 

 

 

 

 

 

 

 

43

 

 

 

1

 

Non-GAAP interest expense, net

 

36

 

 

 

6

 

 

 

6

 

 

 

48

 

 

 

17

 

Net income

$

6

 

 

$

130

 

 

$

132

 

 

$

279

 

 

$

401

 

Interest expense, net

 

79

 

 

 

6

 

 

 

6

 

 

 

91

 

 

 

18

 

Provision for income taxes

 

34

 

 

 

26

 

 

 

34

 

 

 

88

 

 

 

86

 

Depreciation

 

17

 

 

 

13

 

 

 

12

 

 

 

43

 

 

 

36

 

Amortization of intangible assets

 

47

 

 

 

15

 

 

 

15

 

 

 

77

 

 

 

40

 

EBITDA

$

183

 

 

$

190

 

 

$

199

 

 

$

578

 

 

$

581

 

Stock-based compensation

 

10

 

 

 

13

 

 

 

9

 

 

 

31

 

 

 

28

 

Acquisition and integration costs (Note 1)

 

31

 

 

 

2

 

 

 

9

 

 

 

41

 

 

 

21

 

Acquisition inventory step-up (Note 2)

 

39

 

 

 

 

 

 

 

 

 

39

 

 

 

 

Restructuring and other (Note 3)

 

5

 

 

 

3

 

 

 

2

 

 

 

10

 

 

 

10

 

Gain on sale of long-lived assets (Note 5)

 

 

 

 

 

 

 

 

 

 

(7

)

 

 

 

Currency hedge loss (gain) (Note 6)

 

 

 

 

 

 

 

3

 

 

 

(5

)

 

 

10

 

Adjusted EBITDA

$

268

 

 

$

208

 

 

$

222

 

 

$

687

 

 

$

650

 

Adjusted EBITDA margin

 

28.0

%

 

 

27.2

%

 

 

29.9

%

 

 

27.9

%

 

 

29.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


MKS Instruments, Inc.

Reconciliation of GAAP Income Tax Rate to Non-GAAP Income Tax Rate

(In millions)

 

 

 

 

Three Months Ended September 30, 2022

 

Three Months Ended June 30, 2022

 

 

Income Before
Income Taxes

 

 

Provision (benefit)
for Income Taxes

 

 

Effective
Tax Rate

 

Income Before
Income Taxes

 

 

Provision (benefit)
for Income Taxes

 

 

Effective
Tax Rate

GAAP

 

$

40

 

 

$

34

 

 

85.5%

 

$

156

 

 

$

26

 

 

17.0%

Acquisition and integration costs (Note 1)

 

 

31

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

Acquisition inventory step-up (Note 2)

 

 

39

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring and other (Note 3)

 

 

5

 

 

 

 

 

 

 

 

3

 

 

 

 

 

 

Amortization of intangible assets

 

 

47

 

 

 

 

 

 

 

 

15

 

 

 

 

 

 

Amortization of debt issuance costs (Note 4)

 

 

43

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reversal of indefinite reinvestment assertion (Note 7)

 

 

 

 

 

(30

)

 

 

 

 

 

 

 

 

 

 

Tax effect of Non-GAAP adjustments (Note 10)

 

 

 

 

 

34

 

 

 

 

 

 

 

 

5

 

 

 

Non-GAAP

 

$

204

 

 

$

37

 

 

18.0%

 

$

176

 

 

$

31

 

 

18.0%

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2021

 

 

 

 

 

 

 

 

Income Before
Income Taxes

 

 

Provision (benefit)
for Income Taxes

 

 

Effective
Tax Rate

GAAP

 

 

 

 

 

 

 

$

166

 

 

$

34

 

 

20.4%

Acquisition and integration costs (Note 1)

 

 

 

 

 

 

 

 

9

 

 

 

 

 

 

Restructuring and other (Note 3)

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

Amortization of intangible assets

 

 

 

 

 

 

 

 

15

 

 

 

 

 

 

Currency hedge loss (gain) (Note 6)

 

 

 

 

 

 

 

 

3

 

 

 

 

 

 

Tax effect of Non-GAAP adjustments (Note 10)

 

 

 

 

 

 

 

 

 

 

 

6

 

 

 

Non-GAAP

 

 

 

 

 

 

 

$

195

 

 

$

40

 

 

20.4%

 

 

 

Nine Months Ended September 30, 2022

 

Nine Months Ended September 30, 2021

 

 

Income Before
Income Taxes

 

 

Provision (benefit)
for Income Taxes

 

 

Effective
Tax Rate

 

Income Before
Income Taxes

 

 

Provision (benefit)
for Income Taxes

 

 

Effective
Tax Rate

GAAP

 

$

367

 

 

$

88

 

 

24.1%

 

$

487

 

 

$

86

 

 

17.6%

Acquisition and integration costs (Note 1)

 

 

41

 

 

 

 

 

 

 

 

21

 

 

 

 

 

 

Acquisition inventory step-up (Note 2)

 

 

39

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring and other (Note 3)

 

 

10

 

 

 

 

 

 

 

 

10

 

 

 

 

 

 

Amortization of intangible assets

 

 

77

 

 

 

 

 

 

 

 

40

 

 

 

 

 

 

Amortization of debt issuance costs (Note 4)

 

 

43

 

 

 

 

 

 

 

 

1

 

 

 

 

 

 

Gain on sale of long-lived assets (Note 5)

 

 

(7

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Currency hedge loss (gain) (Note 6)

 

 

(5

)

 

 

 

 

 

 

 

10

 

 

 

 

 

 

Reversal of indefinite reinvestment assertion (Note 7)

 

 

 

 

 

(30

)

 

 

 

 

 

 

 

 

 

 

Windfall tax benefit on stock-based compensation (Note 8)

 

 

 

 

 

1

 

 

 

 

 

 

 

 

4

 

 

 

Withholding tax related to Brexit (Note 9)

 

 

 

 

 

 

 

 

 

 

 

 

 

(3

)

 

 

Tax effect of Non-GAAP adjustments (Note 10)

 

 

 

 

 

42

 

 

 

 

 

 

 

 

16

 

 

 

Non-GAAP

 

$

565

 

 

$

101

 

 

17.9%

 

$

569

 

 

$

103

 

 

18.2%

 


MKS Instruments, Inc.
Reconciliation of Net Leverage Ratio

(In millions)

 

 

Three Months Ended

 

 

 

 

 

September 30,

 

 

June 30,

 

 

March 31,

 

 

December 31,

 

 

 

 

 

2022

 

 

2022

 

 

2022

 

 

2021

 

 

Total

 

Combined Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

$

(12

)

 

$

150

 

 

$

187

 

 

$

175

 

 

$

500

 

Interest expense, net

 

105

 

 

 

21

 

 

 

20

 

 

 

19

 

 

 

165

 

Provision for income taxes

 

33

 

 

 

51

 

 

 

46

 

 

 

46

 

 

 

176

 

Depreciation and amortization

 

73

 

 

 

65

 

 

 

67

 

 

 

69

 

 

 

274

 

Stock-based compensation

 

13

 

 

 

17

 

 

 

11

 

 

 

13

 

 

 

54

 

Acquisition and integration costs

 

71

 

 

 

2

 

 

 

9

 

 

 

15

 

 

 

97

 

Acquisition inventory step-up

 

39

 

 

 

 

 

 

 

 

 

 

 

 

39

 

Restructuring and other

 

5

 

 

 

3

 

 

 

3

 

 

 

4

 

 

 

15

 

Gain on sale of long-lived assets

 

 

 

 

 

 

 

(7

)

 

 

 

 

 

(7

)

Currency hedge loss (gain)

 

 

 

 

 

 

 

(5

)

 

 

 

 

 

(5

)

Management fee

 

 

 

 

1

 

 

 

1

 

 

 

1

 

 

 

3

 

Adjusted EBITDA

$

327

 

 

$

310

 

 

$

332

 

 

$

342

 

 

$

1,311

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Principal outstanding on New Credit Agreement at September 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

$

5,189

 

Less: Cash & Short Term Investments at September 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

885

 

Net debt at September 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

$

4,304

 

Net leverage ratio at September 30, 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

3.3

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MKS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

$

54

 

 

$

130

 

 

$

143

 

 

$

150

 

 

$

477

 

Interest expense, net

 

79

 

 

 

6

 

 

 

6

 

 

 

6

 

 

 

97

 

Provision for income taxes

 

44

 

 

 

26

 

 

 

28

 

 

 

29

 

 

 

127

 

Depreciation and amortization

 

28

 

 

 

28

 

 

 

28

 

 

 

28

 

 

 

112

 

Stock-based compensation

 

10

 

 

 

13

 

 

 

8

 

 

 

9

 

 

 

40

 

Acquisition and integration costs

 

30

 

 

 

2

 

 

 

8

 

 

 

9

 

 

 

49

 

Restructuring and other

 

 

 

 

3

 

 

 

2

 

 

 

1

 

 

 

6

 

Gain on sale of long-lived assets

 

 

 

 

 

 

 

(7

)

 

 

 

 

 

(7

)

Currency hedge loss (gain)

 

 

 

 

 

 

 

(5

)

 

 

 

 

 

(5

)

Adjusted EBITDA

$

245

 

 

$

208

 

 

$

211

 

 

$

232

 

 

$

896

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Atotech

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

$

(66

)

 

$

20

 

 

$

44

 

 

$

25

 

 

$

23

 

Interest expense, net

 

26

 

 

 

15

 

 

 

14

 

 

 

13

 

 

 

68

 

Provision for income taxes

 

(11

)

 

 

25

 

 

 

18

 

 

 

17

 

 

 

49

 

Depreciation and amortization

 

45

 

 

 

37

 

 

 

39

 

 

 

41

 

 

 

162

 

Stock-based compensation

 

3

 

 

 

4

 

 

 

3

 

 

 

4

 

 

 

14

 

Acquisition and integration costs

 

41

 

 

 

 

 

 

1

 

 

 

6

 

 

 

48

 

Acquisition inventory step-up

 

39

 

 

 

 

 

 

 

 

 

 

 

 

39

 

Restructuring and other

 

5

 

 

 

 

 

 

1

 

 

 

3

 

 

 

9

 

Management fee

 

 

 

 

1

 

 

 

1

 

 

 

1

 

 

 

3

 

Adjusted EBITDA

$

82

 

 

$

102

 

 

$

121

 

 

$

110

 

 

$

415

 

Combined Company combines the results of MKS (excluding Atotech/Materials Solutions Division for the three months ended September 30, 2022) and the results of Atotech (including full quarter results for the three months ended September 30, 2022).

 

 


MKS Instruments, Inc.
Notes on Our Non-GAAP Financial Information



Non-GAAP financial measures adjust GAAP financial measures for the items listed below. These Non-GAAP financial measures should be viewed in addition to, and not as a substitute for, MKS' reported GAAP results, and may be different from Non-GAAP financial measures used by other companies. In addition, these Non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. MKS management believes the presentation of these Non-GAAP financial measures is useful to investors for comparing prior periods and analyzing ongoing business trends and operating results. Totals presented may not sum due to rounding.

 

Note 1: Acquisition and integration costs during the three and nine months ended September 30, 2022 and the three months ended June 30, 2022 primarily related to the Atotech Acquisition. Acquisition and integration costs during the three and nine months ended September 30, 2021 primarily related to our acquisition of Photon Control and the Atotech Acquisition. Acquisition and integration costs during the nine months ended September 30, 2021 also included costs related to a proposed acquisition that was not consummated.

 

Note 2: Costs of revenues during the three and nine months ended September 30, 2022 include the amortization from the step-up of inventory to fair value as a result of the Atotech Acquisition.

 

Note 3: Restructuring and other costs during the three months ended September 30, 2022 primarily related to executive payments made related to the Atotech Acquisition. Restructuring and other costs during the three months ended June 30, 2022 primarily related to severance costs due to a global cost-saving initiative and the closure of two facilities in Europe. Restructuring and other costs during the nine months ended September 30, 2022 primarily related to executive payments made related to the Atotech Acquisition and severance costs due to a global cost-saving initiative and the closure of two facilities in Europe. Restructuring and other costs during the three and nine months ended September 30, 2021 primarily related to duplicate facility costs attributed to entering into new facility leases, severance costs due to a global cost saving initiative, costs related to the closure of two facilities in Europe and movement of certain products to low-cost regions.

 

Note 4: We recorded additional interest expense related to the amortization of debt issuance costs associated with our new and prior term loan facilities.

 

Note 5: We recorded a gain on the sale of a minority interest investment in a private company.

 

Note 6: We realized a gain in the nine months ended September 30, 2022 from a euro currency contract used to hedge our financing in connection with the acquisition of Atotech. The contract expired on January 31, 2022. We recorded a fair-value loss in the three and nine months ended September 30, 2021 from Canadian dollar contracts used to hedge the funding of our acquisition of Photon Control.

 

Note 7: We no longer intend to indefinitely reinvest earnings of our foreign subsidiaries after the Atotech Acquisition. Additional income tax expense was recorded to reflect an estimate of withholding taxes that would be due on repatriation of prior period earnings.

 

Note 8: We recorded windfall tax benefits on the vesting of stock-based compensation.

 

Note 9: We recorded additional withholding taxes on intercompany undistributed earnings following the United Kingdom’s withdrawal from the European Union.

 

Note 10: Non-GAAP adjustments are tax effected at applicable statutory rates resulting in a difference between the GAAP and Non-GAAP tax rates.